What was known before {#section21-2054358120917780}
=====================

Patients on hemodialysis (HD) are disproportionately frail in comparison with age-matched non-HD counterparts. Cross-sectional measurements of frailty on HD are associated with adverse outcomes that are well documented.

What this adds {#section22-2054358120917780}
==============

This is the first Canadian study looking at longitudinal frailty assessments in patients on hemodialysis (HD). The study explores the relationship between the frailty status and level of independence, mood, cognition, and QoL at 2 different time points (at baseline and at 1 year).

Introduction {#section23-2054358120917780}
============

Frailty is an all-embracing syndrome of diminished physiological reserve to stressors resulting in reduced physical ability and increased vulnerability to hospitalization and mortality.^[@bibr1-2054358120917780]^ In the non-chronic kidney disease (CKD) population, frailty has been linked to a variety of outcomes, such as falls,^[@bibr2-2054358120917780]^ fractures,^[@bibr3-2054358120917780]^ dementia,^[@bibr4-2054358120917780]^ and hospitalization.^[@bibr5-2054358120917780]^ In addition, there are published data on cross-sectional frailty assessments and their subsequent relationship to mobility,^[@bibr1-2054358120917780]^ quality of life (QoL),^[@bibr6-2054358120917780]^ depression,^[@bibr7-2054358120917780]^ cognitive decline,^[@bibr8-2054358120917780]^ nursing home admissions,^[@bibr9-2054358120917780]^ and disability.^[@bibr10-2054358120917780]^ The prevalence of frailty is disproportionately increased in patients with CKD in comparison with non-CKD counterparts.^[@bibr11-2054358120917780],[@bibr12-2054358120917780]^ It is the highest in patients with end-stage kidney disease (ESKD).^[@bibr13-2054358120917780]^ The most widely used definition in literature is known as the Fried frailty phenotype.^[@bibr14-2054358120917780]^ It is based on 5 physical domains that can be assessed by self-report (weight loss, low physical activity, and exhaustion) and objective measures (weakness and slow gait speed). Based on the number of deficits, individuals are characterized as robust (0), prefrail (1-2/5), and frail (≥3/5).^[@bibr1-2054358120917780]^

In a meta-analysis by Kojima and published in 2017, the pooled prevalence of measured frailty among patients on dialysis was 36.8% and upon self-report was 67.0%.^[@bibr15-2054358120917780]^ Most studies on patients receiving hemodialysis (HD) have used 1-time measures of frailty (either cross-sectionally or at dialysis initiation) in determining subsequent health outcomes.^[@bibr16-2054358120917780],[@bibr17-2054358120917780]^ There is a paucity of longitudinal studies addressing changes in frailty status to level of dependence, decline in cognition, mood, and QoL. The associations between changes in frailty to the level of independence and the subsequent need for institutionalization have not yet been explored in detail. In this prospective study, we attempted to (1) evaluate changes in frailty status, level of independence, mood, cognition, and QoL over a 12-month period and (2) explore the relationship between frailty status and level of independence, mood, cognition, and QoL at 2 different time points (at baseline and at 1 year).

Methods {#section24-2054358120917780}
=======

Study Design {#section25-2054358120917780}
------------

We analyzed a cohort of 100 prevalent HD patients at the Regina General Hospital and Wascana Dialysis Unit in Regina, Saskatchewan, Canada, between January 2015 and January 2017. The patients underwent baseline and 1-year follow-up frailty assessments, as routine clinical care. The patients were recruited if they met the following inclusion criteria: (1) age \>18 years, (2) on scheduled dialysis, (3) on dialysis for \>6 months, (4) fluency in English, and (5) sufficient visual and hearing acuity. The exclusion criteria included the following: (1) patients on dialysis with acute kidney injury with a likelihood of recovery, (2) transient in center dialysis (3) concurrent treatment on peritoneal dialysis or home HD, (4) active malignancy, (5) imminent geographic relocation, (6) pregnancy, (7) significant mental illness, and (8) previous or approved transplants. The Research Ethics Board of the former Regina Qu'Appelle Health Region (REB--19--17) approved the study.

Patient Characteristics {#section26-2054358120917780}
-----------------------

Demographic variables (age, gender, and ethnicity) were ascertained from patient charts. Age was categorized as a binary variable (≥ or \<65 years). The level of education was enquired during assessment. Body mass index (BMI) was calculated in kilogram/square meter from self-reported height and pre-HD weight at the time of assessment. Self-reported outcomes (level of independence) were recorded at each assessment. Comorbidities (diabetes \[type I or II\], hypertension, dyslipidemia, and peripheral vascular disease), predialysis blood pressure, and length of time since dialysis initiation were obtained from electronic medical records---Medical Information Quality System (MIQS, Denver, Colorado, USA).

*Frailty* was measured using the Fried frailty phenotype, a valid measure of frailty that is used as a screening tool in CKD literature. Fried frailty phenotype scores were assessed at cohort entry and 1-year follow-up (in patients who survived). All physical assessments were completed before dialysis, and questionnaires were completed during the first hour of HD treatment. The criteria include 5 physical components: slowness, weakness, weight loss, low physical activity, and exhaustion. Each component received a score of 0 or 1 based on the following criteria ([Supplemental Appendix 1](https://journals.sagepub.com/doi/suppl/10.1177/2054358120917780)). Patients with a score of 3 or more were classified as frail, a score of 1 to 2 were defined as prefrail, and a score of 0 were considered robust. In addition to frailty assessments, patients underwent questionnaires for cognitive assessment, depression, and QoL. They were enquired about their levels of dependence with activities of daily living. Patients were approached by phone on nondialysis days, and a mutually agreed time and date were identified for assessment upon obtaining verbal consent for frailty assessment.

-   *Slowness* was assessed based on a 4-m walk (walking speed \>5 seconds). The time taken for the patient to walk was measured. The average time of the 2 walks was used for scoring. If the patient was unable to walk, then speed was not recorded, received a score of 1, and were categorized as slow. If they walked with assistance, then the average time of 2 walks was used.

-   *Weakness* was assessed on handgrip strength measured using Jamar Hydraulic Hand Dynamometer (Model 5030J1, Sammons Preston Rolyan, Bolingbrook, IL, USA). Patients performed 2 attempts on the nonfistula arm. The highest value in kilograms (kg) for muscle strength was used to calculate the score. A score below an established cutoff, based on gender (male ≤30 kg, female ≤20kg), was considered as weakness.

-   *Weight loss* was based on unintentional ≥4.5-kg (predialysis) reduction in weight over the preceding 12 months.

-   *Low physical activity* was determined by the Paffenbarger Physical Activity Index Questionnaire ([Supplemental Appendix 2](https://journals.sagepub.com/doi/suppl/10.1177/2054358120917780)). The patients were asked about the frequency and duration of activities over 1 week. A score below an established cutoff, based on gender (male \<383 kcal/wk, female \<270 kcal/wk), was considered as low activity.

-   *Exhaustion* was based on 2 questions from the Center for Epidemiologic Studies Depression (CES-D) scale ([Supplemental Appendix 3](https://journals.sagepub.com/doi/suppl/10.1177/2054358120917780)). A score above an established cutoff (≥2) was defined as exhaustion.

*Cognitive function* was measured at each assessment visit using the Montreal Cognitive Assessment (MoCA, English version 7.1 available at [www.mocatest.org](http://www.mocatest.org); [Supplemental Appendix 4](https://journals.sagepub.com/doi/suppl/10.1177/2054358120917780)). The test was conducted before HD or during the first hour of the session. The MoCA is highly sensitive and evaluates multiple cognitive domains, including visuospatial ability and executive function (/5), naming (/3), memory (/5), attention (/6), language (/3), abstraction (/2), and orientation (/6). The total possible score is 30 points. However, for participants with ≤12 years of formal education, 1 extra point is added. The cutoff score ≤ 24 was considered cognitive impairment.^[@bibr18-2054358120917780],[@bibr19-2054358120917780]^

### Depression {#section27-2054358120917780}

Five-item Geriatric Depression Scale (GDS) screen questionnaire was administered to identify symptoms of depression in patients at baseline and follow-up assessment. The test was developed by Hoyl et al in 1999^[@bibr20-2054358120917780]^ and is a validated tool for depression screening.^[@bibr21-2054358120917780]^ The 5-item GDS consists of 5 questions; a score ≥2 is suggestive of depression ([Supplemental Appendix 5](https://journals.sagepub.com/doi/suppl/10.1177/2054358120917780)).

### Level of independence {#section28-2054358120917780}

Information on the level of independence and institutionalization status was ascertained from patients or caregivers at the time of assessment(s). Four levels of independence based on feeding, dressing, ambulation, grooming, using a toilet, and bathing were defined: (1) independent (did not require assistance with activities of daily living from family and friends), (2) independent with support (required assistance with activities of daily living from a family member/friend), (3) home care recipient (lived at home but received assistance from personal care services), and (4) long-term care home resident and assisted living.

### Quality of life {#section29-2054358120917780}

Health-related QoL was measured using a self-reported questionnaire, 3-level version of EuroQol-5 dimensions (EQ-5D-3L) at the time of assessment(s) (available at [www.euroqol.org](http://www.euroqol.org); [Supplemental Appendix 6](https://journals.sagepub.com/doi/suppl/10.1177/2054358120917780)). EQ-5D-3L includes 2 sections: EQ-5D descriptive system and EQ-5D visual analog scale (VAS). EQ-5D-3L measures 5 dimensions (mobility, self-care, daily activities, pain/discomfort, anxiety/depression) with 3 levels each (no/moderate/severe problem, labeled 1, 2, 3, respectively). The patient selected the most appropriate answer in each of the 5 dimensions. EQ-5D-3L health states were converted into a single index value "utility score." Since the data for Canada are not available, we used the scores based on the USA general population perspectives. The utility score ranges between −1.109 and 1, where a score below 0 reflects a health state worse than death, 0 means death, and 1 is the best health state. We converted health state into a utility score using formulas available at <https://www.economicsnetwork.ac.uk/health/EQ_5D_index_calculator.xls>. For example "health state" 12321 was converted to "utility score" 0.546 in our study population. The EQ-5D VAS records the patient's self-rated health (0-100) on a vertical scale, where 100 is the "best imaginable health state" and 0 is the "worst imaginable health state" ([Supplemental Appendix 7](https://journals.sagepub.com/doi/suppl/10.1177/2054358120917780)).

Statistical Analysis {#section30-2054358120917780}
--------------------

Variables were reported as count (%), mean ± standard deviation (SD), or medians with interquartile range (IQR) as appropriate. Frailty status was reported as a binary variable: frail vs. nonfrail (prefrail and robust). We also dichotomized the EQ-5D levels into "no problems" (level 1) and "problems" (levels 2 and 3) and reported the frequencies of problems. McNemar's test was used to compare categorical variables (frailty, frailty components, cognitive impairment, depression, and EQ-5D dimensions) between baseline and 1-year follow-up. Wilcoxon signed-rank test was used to compare variables such as the MoCA score, GDS score, EQ-5D utility score, and EQ-VAS between baseline and 1-year follow-up. We tested whether frailty was associated with cognitive function, mood, QoL, and level of dependence using the chi-square test or Fisher's exact test where appropriate. Differences in variables such as MoCA score, GDS score, EQ-5D utility score, and EQ-VAS between frail and nonfrail groups were assessed using the Mann--Whitney Test. The significance level was set as α = .05. Statistical analyses were performed with SPSS Statistics for Windows, Version 22.0 (SPSS Inc., Chicago, Illinois).

Results {#section31-2054358120917780}
=======

Ninety-seven of the 100 enrolled patients had complete baseline assessments. At 1-year follow-up, 22 patients died, 10 refused to follow-up assessments, and 3 were lost to follow-up, leaving 65 patients for 1-year follow-up assessment ([Figure 1](#fig1-2054358120917780){ref-type="fig"}). At baseline, the mean age ± SD in years was 63 ± 15. A total of 58% were men, 73% were Caucasian, 51% were diabetic, and the mean BMI ± SD was 29.33 ± 7.26 ([Table 1](#table1-2054358120917780){ref-type="table"}). The median time on dialysis (IQR) in months before the initial assessment was 35.5 (13.75-71.75). The prevalence of frailty, prefrailty, and robust was 68%, 27%, and 5%, respectively. Half of the frail patients were men; 54.5% were ≥65 years old ([Table 2](#table2-2054358120917780){ref-type="table"}).

###### 

Patients' Demographics and Comorbidities at Baseline and 1-Year Follow-Up.

![](10.1177_2054358120917780-table1)

  Characteristics                    Baseline             1-year follow-up   N
  ---------------------------------- -------------------- ------------------ --------------------------------------
  Age (years)                        62.86 ± 15.44        64.35 ± 14.88      Baseline: n = 100; Follow-up: n = 65
   \<65                              51 (51%)             34 (52.3%)         
   ≥65                               49 (49%)             31 (47.7%)         
  Gender (female)                    42 (42%)             25 (38.5%)         Baseline: n = 100; Follow-up: n = 65
  Ethnicity                                                                  
   Caucasian                         73 (73%)             49 (75.4%)         Baseline: n = 100; Follow-up: n = 65
   Aboriginal                        21 (21%)             10 (15.4%)         
   Asian                             6 (6%)               6 (9.2%)           
  Education                                                                  
   ≤12 years of education            63 (63%)             41 (63%)           Baseline: n = 100; Follow-up: n = 65
   \>12 years of education           37 (37%)             24 (37%)           
  Weight (kg)                        83.99 ± 23.41        84.88 ± 24.51      Baseline: n = 100; Follow-up: n = 65
  Height (cm)                        168.89 ± 9.44        169.18 ± 8.90      Baseline: n = 100; Follow-up: n = 65
  Body mass index (kg/m^2^)          29.33 ± 7.26         29.49 ± 7.45       Baseline: n = 100; Follow-up: n = 65
  Systolic blood pressure (mm Hg)    135.28 ± 25.10       136.14 ± 29.42     Baseline: n = 100; Follow-up: n = 65
  Diastolic blood pressure (mm Hg)   72.97 ± 13.59        72.29 ± 17.02      Baseline: n = 100; Follow-up: n = 65
  Comorbidities                                                              
   Diabetes I or II                  44 (51.2%)           30 (52.6%)         Baseline: n = 86; Follow-up: n = 57
   Peripheral vascular diseases      7 (8.1%)             10 (17.5%)         
   Hypertension                      68 (79.6%)           43 (75.4%)         
   Dyslipidemia                      15 (17.4%)           19 (33.3%)         
  Vintage of dialysis (months)       35.5 (13.75-71.75)   47 (29-88)         Baseline: n = 100; Follow-up: n = 65

###### 

Results at Initial Assessment and 1-Year Follow-Up.

![](10.1177_2054358120917780-table2)

  Characteristics             Baseline           1-year follow-up   N
  --------------------------- ------------------ ------------------ --------------------------------------
  Frail (≥3)                  66 (68.1%)         44 (67.7%)         Baseline: n = 97; Follow-up: n = 65
   Gender (female)            33 (50%)           20 (45.4%)         
   ≥65 years                  36 (54.5%)         21 (47.7%)         
   Age (years)                65.0 ± 13.86       64.0 ± 15.24       
  Prefrail (1-2)              26 (26.8%)         17 (26.1%)         
  Robust (0)                  5 (5.1%)           4 (6.2%)           
  MoCA score (≤24)            69 (69%)           40 (64.5%)         Baseline: n = 100; Follow-up: n = 62
   Gender (female)            26 (37.7%)         12 (30%)           
   ≥65 years                  42 (60.9%)         18 (45%)           
   Age (years)                67.11 ± 14.04      64.25 ± 13.54      
  GDS score (≥2)              50 (52.8%)         31 (47.7%)         Baseline: n = 96; Follow-up: n = 65
   Gender (female)            18 (36%)           8 (25.8%)          
   ≥65 years                  23 (46%)           9 (29.1%)          
   Age (years)                61.04 ± 15.98      59.48 ± 13.76      
  EQ-5D utility score         0.81 (0.70-0.85)   0.77 (0.69-0.84)   Baseline: n = 100; Follow-up: n = 65
  EQ-VAS                      60 (44-80)         50 (45-80)         Baseline: n = 100; Follow-up: n = 63
  Level of dependence                                               
   Independent                82 (82%)           41 (63.1%)         Baseline: n = 100; Follow-up: n = 65
   Independent with support   17 (17%)           20 (30.8%)         
   Home care                  1 (1%)             2 (3.1%)           
   Long-term care home        0 (0%)             2 (3.1%)           

*Note*. Frailty was measured using 5-item Fried frailty criteria, frail: ≥3 criteria present, prefrail: 1 or 2 criteria present, robust: 0 criteria present. Cognitive function was measured using the MoCA, cognitive impaired: MoCA score ≤ 24. Depressive symptoms were identified using 5-item GDS questionnaire, depressed: GDS score≥ 2. Quality of life was measured using EQ-5D; EQ-5D utility score: 0 means death and 1 is the best health state; EQ-VAS: 0 is the worst imaginable health state and 100 is the best imaginable health state. EQ-5D-3L = EuroQol-5 dimensions-3 levels; MoCA = Montreal Cognitive Assessment; GDS = Geriatric Depression Scale; EQ-VAS = EuroQol visual analog scale.

![Study flow chart.](10.1177_2054358120917780-fig1){#fig1-2054358120917780}

In comparison with baseline vs. 1 year, the number of frail patients was 68.1% vs. 67.7%, prefrail 26.8% vs. 26.1%, and robust 5.1% vs. 6.2%. Similarly, in comparison with baseline vs. 1 year, the number of independent patients were 82% vs. 63%; independent with support 17% vs. 31%; long-term care home 0% vs. 3.1%; MoCA ≤24, 69% vs. 64.5%; GDS score ≥2, 52.8% vs. 47.7%; median EQ-5D utility score 0.81 vs. 0.77; and median EQ-VAS 60 vs 50; [Table 2](#table2-2054358120917780){ref-type="table"}.

Our results showed that frailty is bidirectional: at 1 year, 5 of the 65 frail patients converted to nonfrail and 7 of the 65 nonfrail patients worsened their frailty status. Among those 5 patients who improved their status, the frailty components that were most commonly affected were walking speed (3/5), energy (exhaustion; CES-D; 2/5), physical activity and weight (1/5), and strength (handgrip test; 0/5). Among those 7 patients who worsened, the most common affected components were energy (exhaustion; CES-D; 5/7), walking speed and physical strength (both 3/7), and physical activity and weight (both 2/7). Analyses showed that the vintage of dialysis was associated with a change in frailty status (*P* = .01). This shows that those who were not frail at baseline and were found to be frail at follow-up (worsened) had a higher vintage of dialysis (68 \[37.5-135.5\] months) than those who were frail (9.0 \[4-20\]) at baseline and became nonfrail at follow-up (improved; [Supplemental Table 1](https://journals.sagepub.com/doi/suppl/10.1177/2054358120917780)).

Frailty and Outcomes {#section32-2054358120917780}
--------------------

The results of characteristics of frail vs. nonfrail at baseline are demonstrated in [Table 3](#table3-2054358120917780){ref-type="table"}, [Figure 2](#fig2-2054358120917780){ref-type="fig"}, and [Supplemental Table 2](https://journals.sagepub.com/doi/suppl/10.1177/2054358120917780). Proportion of patients with ≤12 years of education in the frail group was lower than nonfrail (27.3% vs. 54.8%, *P* = .01). There was no statistical difference between frail and nonfrail in terms of age, gender, ethnicity, BMI, comorbidity, and vintage of dialysis ([Supplemental Table 2](https://journals.sagepub.com/doi/suppl/10.1177/2054358120917780)).

###### 

Comparisons of Baseline Characteristics by Frailty Group.

![](10.1177_2054358120917780-table3)

  -------------------------------------------------------------------------------
  Characteristics        Frail              Nonfrail        *P* value
  ---------------------- ------------------ --------------- ---------------------
  Cognitive impaired     n = 66\            n = 31\         *P* = .076, n = 97
                         50 (75.8%)         18 (58.1%)      

  MoCA score (≤24)       n = 66\            n = 31\         *P* = .006, n = 97
                         21 (15.75-24.25)   24 (21-26)      

  Depressive symptoms    n = 63\            n = 31\         *P* = .214, n = 94
                         35 (55.6%)         13 (42%)        

  GDS score (≥2)         n = 63\            n = 31\         *P* = .068, n = 94
                         2 (1-4)            1 (0-3)         

  EQ-5D-3L dimensions    n = 66             n = 31          

   Mobility\             52 (78.8%)         11 (35.5%)      *P* \< .001
   Problems                                                 

   Self-care\            9 (13.7%)          30 (96.8%)      *P* = .161
   Problems                                                 

   Daily activities\     36 (54.6%)         16 (51.6%)      *P* = .571
   Problems                                                 

   Pain/discomfort\      50 (75.8%)         18 (58%)        *P* = .001
   Problems                                                 

   Anxiety/depression\   21 (31.8%)         7 (22.6%)       *P* = .349
   Problems                                                 

  EQ-5D utility score    n = 66\            n = 31\         *P* \< .001, n = 97
                         0.79 (0.71-0.83)   0.85 (0.79-1)   

  EQ-VAS                 n = 66\            n = 31\         *P* = .111, n = 97
                         50 (40-75)         60 (50-80)      
  -------------------------------------------------------------------------------

*Note*. Frailty was measured using 5-item Fried frailty criteria, frail: ≥3 criteria present, nonfrail: \<3, nonfrail was considered the combination of robust and prefrail. Cognitive function was measured using the MoCA: the highest possible score is 30, cognitive impaired: MoCA score ≤24. Depressive symptoms were identified using 5-item GDS questionnaire: the worst possible score is 5, depressed: GDS score ≥ 2. Quality of life was measured using EQ-5D; problems in each dimension were considered the combination of moderate and extreme problems. EQ-5D utility score: 0 means death and 1 is the best health state; EQ-VAS: 0 is the worst imaginable health state and 100 is the best imaginable health state. EQ-5D-3L = EuroQol-5 dimensions-3 levels; MoCA = Montreal Cognitive Assessment; GDS = Geriatric Depression Scale; EQ-VAS = EuroQol visual analog scale.

![Frailty and level of dependence at baseline.\
*Note.* Frailty was measured using 5-item Fried frailty criteria: Frail: ≥3 criteria present, nonfrail: \<3, nonfrail was considered the combination of robust and prefrail. Each bar shows the proportion of patients who are independent, independent with support, and home care recipient in frail and nonfrail groups (baseline). Of the 97 patients, 66 were frail. In the frail group, 51 (77.3%) were independent, 14 (21.2%) were independent with support, and 1 (1.5%) was home care recipient. In the nonfrail group, 30 (96.8%) were independent and 1 (3.2%) was independent with support.](10.1177_2054358120917780-fig2){#fig2-2054358120917780}

In patients who were available for the second assessments (n = 65), we compared frail vs. nonfrail (composite of robust and prefrail) outcomes at 1 year. The median (IQR) MoCA was 24 (19-25) vs. 25 (21-26), *P* = .039, and median (IQR) GDS was 2 (1-3) vs. 1 (0-2), *P* = .034. Likewise, median (IQR) EQ-5D utility score was 0.78 (0.6-0.82) vs. 0.81 (0.78-0.85), *P =* .023. There were significant changes in self-care (27% vs 0%), *P* = .006, and daily activities (68.2% vs. 38.1%), *P* = .021 ([Table 4](#table4-2054358120917780){ref-type="table"} and [Figure 3](#fig3-2054358120917780){ref-type="fig"}). At 1-year, 22 patients died, 18 of the 22 (82.0%) were frail and 3 of the 22 (18.0%) were nonfrail. Eighteen of the 66 (27.3%) frail patients and 4 of the 31 (9.7%) nonfrail patients died at 1 year, respectively. The comparison of characteristics between baseline and 1 year are shown in [Supplemental Table 3](https://journals.sagepub.com/doi/suppl/10.1177/2054358120917780).

###### 

Comparisons of 1-Year Follow-Up Characteristics by the Frailty Group.

![](10.1177_2054358120917780-table4)

  --------------------------------------------------------------------------------
  Characteristics        Frail             Nonfrail           *P* value
  ---------------------- ----------------- ------------------ --------------------
  Cognitive impaired     n = 41\           n = 21\            *P* = .047, n = 62
                         30 (73.2%)        10 (47.7%)         

  MoCA score (≤24)       n = 41\           n = 21\            *P* = .039, n = 62
                         24 (19-25)        25 (21-26)         

  Depressive symptoms    n = 44\           n = 21\            n = 65, *P* = .109
                         24 (54.6%)        7 (33.3%)          

  GDS score (≥2)         n = 44\           n = 21\            *P* = .034, n = 65
                         2 (1-3)           1 (0-2)            

  EQ-5D-3L dimensions    n = 44            n = 21             

   Mobility\             40 (90.9%)        15 (71.4%)         *P* = .065
   Problems                                                   

   Self-care\            12 (27.3%)        0 (0%)             *P* = .006
   Problems                                                   

   Daily activities\     30 (68.2%)        8 (38.1%)          *P* = .021
   Problems                                                   

   Pain/discomfort\      30 (68.2%)        11 (52.4%)         *P* = .217
   Problems                                                   

   Anxiety/depression\   17 (38.6%)        7 (33.3%)          *P* = .679
   Problems                                                   

  EQ-5D utility score    n = 44\           n = 21\            *P* = .023, n = 65
                         0.78 (0.6-0.82)   0.81 (0.78-0.85)   

  EQ-VAS                 n = 43\           n = 20\            *P* = .286, n = 63
                         50 (40-75)        65 (46.25-80)      
  --------------------------------------------------------------------------------

*Note.* Frailty was measured using 5-item Fried frailty criteria, frail: ≥3 criteria present, nonfrail: \<3, nonfrail was considered the combination of robust and prefrail. Cognitive function was measured using the MoCA: the highest possible score is 30, cognitive impaired: MoCA score ≤24. Depressive symptoms were identified using 5-item GDS questionnaire: the worst possible score is 5, depressed: GDS score ≥ 2. Quality of life was measured using EQ-5D; problems in each dimension were considered the combination of moderate and extreme problems. EQ-5D utility score: 0 means death and 1 is the best health state; EQ-VAS: 0 is the worst imaginable health state and 100 is the best imaginable health state. EQ-5D-3L = EuroQol-5 dimensions-3 levels; MoCA = Montreal Cognitive Assessment; GDS = Geriatric Depression Scale; EQ-VAS = EuroQol visual analog scale.

![Frailty and level of dependence at 1**-**year follow**-**up.\
*Note.* Frailty was measured using 5-item Fried frailty criteria: Frail: ≥3 criteria present, nonfrail: \<3, nonfrail was considered the combination of robust and prefrail. Each bar shows the proportion of patients who are independent, independent with support, home care recipient, and long-term care home residents in the frail and nonfrail groups (1 year). Of the 65 patients, 44 were frail. In the frail group, 22 (50%) were independent, 19 (43.2%) were independent with support, 1 (2.3%) was home care recipient, and 2 (4.5%) were long-term care home resident. In the nonfrail group, 19 (90.4%) were independent, 1 (4.8%) was independent with support, and 1 (4.8%) was independent with support.](10.1177_2054358120917780-fig3){#fig3-2054358120917780}

Discussion {#section33-2054358120917780}
==========

To our knowledge, this is the first Canadian study that evaluates relationship between frailty and level of independence, mood, cognition, and QoL at 2 different time points. We describe high prevalence (95%) of frail and prefrail status at baseline which remained unchanged 1 year later. Frailty was observed in 65% of patients which is similar to Bao et al^[@bibr17-2054358120917780]^ but higher than others.^[@bibr22-2054358120917780],[@bibr23-2054358120917780]^ We noticed that frail patients on dialysis were older and had challenges with mobility and self-care in comparison with their nonfrail counterparts. Quality of life is defined by the World Health Organization (WHO) as an individual's perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards, and concerns.^[@bibr24-2054358120917780]^ Several studies involving patients with CKD have demonstrated an association between poor QOL measures and greater hospitalization and mortality.^[@bibr25-2054358120917780],[@bibr26-2054358120917780]^ We found a decline at 1 year in QoL dimensions (mobility and self-care), and frail patients required greater assistance from their family members, additional home care support and were twice as likely to need support from home care and transition to nursing home care.

We observed that a significant proportion (69%) of our patients had cognitive impairment at baseline, and there was further decline after 12 months. Cognitive impairment has been shown to impair patients' ability to adhere to HD schedules, fluid, and dietary restrictions.^[@bibr27-2054358120917780]^ We used the MoCA test as it has been identified to assess executive functioning in patients with CKD/HD. The prevalence of cognitive impairment in our study was similar to other published studies estimated to be between 50% and 80%.^[@bibr28-2054358120917780][@bibr29-2054358120917780]-[@bibr30-2054358120917780]^ The prevalence of depression in our study was 53% which is similar to Jaber et al^[@bibr31-2054358120917780]^ but higher than other studies.^[@bibr22-2054358120917780]^ There is a growing body of evidence that depression is associated with poor outcomes such as post dialysis fatigue, higher mortality, and hospitalizations. There was a substantial overlap among frailty, cognition, and depression. At baseline, 29% of our patients were collectively frail, cognitively impaired, and had depressive symptoms. The trajectory of depression and cognitive impairment did not change over 12-month follow-up.

Studies from the geriatric population have shown that frail older people are exceedingly vulnerable to adverse health outcomes, such as falls, prolonged hospitalization, institutionalization, and death.^[@bibr32-2054358120917780][@bibr33-2054358120917780]-[@bibr34-2054358120917780]^ In non-ESKD patients, routine assessments of frailty have been shown to prognosticate risk, determine who may or may not benefit from aggressive interventions, and also to postulate when interventions are likely to be futile.^[@bibr35-2054358120917780]^ Even though death was not a prespecified endpoint, we found that a fifth of our patients (22/100) had died by the time of the next assessment in 12 months. Eighteen of the 22 (82%) had been identified as frail, suggesting majority of the deaths had as anticipated occurred in frail patients. We did not link the data for hospitalizations, but the patients with ESKD irrespective of their frailty status are at a greater risk of hospitalizations compared with non-CKD cohorts.^[@bibr36-2054358120917780]^ This risk is increased further in frail individuals.^[@bibr36-2054358120917780]^ Frail patients are more susceptible to large declines in health status from minor illnesses. Hospitalizations are likely to be longer and lead to further functional decline, and subsequent requirement of additional support systems, and transition to nursing homes.^[@bibr37-2054358120917780]^

The trajectory from robustness to frailty occurs over the journey of CKD and is associated with significant sarcopenia. On a more positive note, it has been recognized that frailty is a dynamic process and patients transition between frail to robust at different time points.^[@bibr32-2054358120917780],[@bibr38-2054358120917780],[@bibr39-2054358120917780]^ We found that at 1 year, 5 of the 65 frail patients converted to nonfrail and 7 of the 65 nonfrail patients worsened their frailty status. Among those 5 patients who improved at 1 year, walking speed improved in 3 patients, and 2 patients no longer met the criteria for exhaustion. Among those 7 patients who worsened at 1 year, 5 patients were more exhausted, 3 walked slower and had weaker grip, and 2 had lower levels of physical activity and had unintentional weight loss). Despite data from our frailty study, we do not yet perform routine frailty assessments in our dialysis units as a means to improve clinical care and cost-effectiveness. Unfortunately, we did not specifically review the reasons for the improvement or the decline when we were conducting the assessments.

It is recognized that early intervention in geriatric frail patients improves QoL and reduces the cost of care. An international consensus group has suggested exercise (resistance and aerobic), caloric and protein support, vitamin D, and reduction in polypharmacy as targeted interventions to assist with frailty.^[@bibr33-2054358120917780]^ Studies involving resistance training and aerobic exercise have shown to decrease hospitalizations, nursing home placements, decrease frailty progression, and disability in orthopedic and community-based programs.^[@bibr40-2054358120917780][@bibr41-2054358120917780]-[@bibr42-2054358120917780]^

Further, there is literature to support that multicomponent exercise training (endurance, flexibility, balance, and resistance training) improves physical function, and sarcopenia which are important components of frailty.^[@bibr43-2054358120917780]^ Our paper supports the need for similar interventions to be initiated in patients with HD as they are high users of emergency rooms, community resources, and hospitalizations.^[@bibr44-2054358120917780]^ Patients with frailty are likely start to dialysis at higher estimated glomerular filtration rates (eGFRs), more likely to avoid fistulas and persist with catheters. Frail older HD and family members are increasingly seeking symptom management and reduction of polypharmacy while on HD over prolongation of life.^[@bibr45-2054358120917780]^ Furthermore, a reduced level of independence leads to caregiver burden and alters family dynamics. As such incorporating frailty assessment and corresponding interventions into routine clinical care has the potential to improve QoL and health outcomes among dialysis patients.

Limitations {#section34-2054358120917780}
-----------

Our patients were receiving dialysis for a median of 36 months prior to undergoing their initial frailty assessments. It would have been ideal if they had undergone assessments at initiation and were followed at yearly intervals. Due to a lack of resources, we were unable to follow patients for greater than a year. Longer longitudinal data would have undoubtedly helped in exploring the associations better. We did not capture data for hospitalizations, but it is well recognized that frail patients are likely to have prolonged hospitalization and the cycle of inactivity while recovering from illness and muscle decompensation adds further to the cycle. It would have also been helpful to have explored associations between mediators of inflammation and oxidative stress in relation to frailty. We did not account for medications that could influence mood and cognition. In addition, we had a small sample size and only 65 patients had a second assessment. This is also a single-center study, so direct inferences must be interpreted in the context of the demographics of the study population.

Conclusion {#section35-2054358120917780}
==========

Nephrologists manage primarily a geriatric population on dialysis and the majority of whom are exceedingly frail. It is also obvious that frailty and prefrailty is near-ubiquitous in our dialysis population and will have to be proactively addressed. Care teams including pharmacists to reduce polypharmacy, psychiatry to assist with mood and cognitive impairment, exercise therapists, dietitians, and social workers will have to work in cohesion to address the multiple aspects of frailty. We hope that larger studies looking at longitudinal frailty assessments will lead to the development of targeted care pathways.
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